Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

44 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A non-diploid DNA status is linked to poor prognosis in renal cell cancer.
Büscheck F, Fraune C, Kluth M, Lennartz M, Simon R, Hube-Magg C, Morlock C, Barbieri S, Wahl C, Eichelberg C, Möller-Koop C, Höflmayer D, Wittmer C, Wilczak W, Sauter G, Fisch M, Eichenauer T, Rink M. Büscheck F, et al. World J Urol. 2021 Mar;39(3):829-837. doi: 10.1007/s00345-020-03226-8. Epub 2020 May 2. World J Urol. 2021. PMID: 32361874 Free PMC article.
Immunohistochemically detected IDH1R132H mutation is rare and mostly heterogeneous in prostate cancer.
Hinsch A, Brolund M, Hube-Magg C, Kluth M, Simon R, Möller-Koop C, Sauter G, Steurer S, Luebke A, Angerer A, Wittmer C, Neubauer E, Göbel C, Büscheck F, Minner S, Wilczak W, Schlomm T, Jacobsen F, Clauditz TS, Krech T, Tsourlakis MC, Schroeder C. Hinsch A, et al. World J Urol. 2018 Jun;36(6):877-882. doi: 10.1007/s00345-018-2225-7. Epub 2018 Feb 9. World J Urol. 2018. PMID: 29427004
Aberrant expression of membranous carbonic anhydrase IX (CAIX) is associated with unfavorable disease course in papillary and clear cell renal cell carcinoma.
Büscheck F, Fraune C, Simon R, Kluth M, Hube-Magg C, Möller-Koop C, Shadanpour N, Bannenberg C, Eichelberg C, Höflmayer D, Clauditz T, Wittmer C, Wilczak W, Sauter G, Fisch M, Rink M, Eichenauer T. Büscheck F, et al. Urol Oncol. 2018 Dec;36(12):531.e19-531.e25. doi: 10.1016/j.urolonc.2018.08.015. Epub 2018 Oct 12. Urol Oncol. 2018. PMID: 30322727
8p deletions in renal cell carcinoma are associated with unfavorable tumor features and poor overall survival.
Eichenauer T, Bannenberg DC, Kluth M, Wittmer C, Büscheck F, Möller K, Dum D, Fraune C, Hube-Magg C, Möller-Koop C, Dahlem R, Fisch M, Rink M, Riechardt S, Tsourlakis MC, Bernreuther C, Minner S, Simon R, Sauter G, Wilczak W, Clauditz TS. Eichenauer T, et al. Urol Oncol. 2020 Feb;38(2):43.e13-43.e20. doi: 10.1016/j.urolonc.2019.09.024. Epub 2019 Nov 19. Urol Oncol. 2020. PMID: 31757738 Free article.
Chromosomal deletion of 9p21 is linked to poor patient prognosis in papillary and clear cell kidney cancer.
Eichenauer T, Simmendinger L, Kluth M, Chirico V, Luebke AM, Höflmayer D, Hinsch A, Jacobsen F, Hube-Magg C, Möller-Koop C, Dahlem R, Fisch M, Rink M, Riechardt S, Tsourlakis MC, Büscheck F, Bernreuther C, Clauditz T, Lebok P, Simon R, Sauter G, Wilczak W, Fraune C. Eichenauer T, et al. Urol Oncol. 2020 Jun;38(6):605.e1-605.e8. doi: 10.1016/j.urolonc.2020.02.022. Epub 2020 Mar 30. Urol Oncol. 2020. PMID: 32241691
Chromosome 17p13 deletion is associated with an aggressive tumor phenotype in clear cell renal cell carcinoma.
Eichenauer T, Shadanpour N, Kluth M, Göbel C, Weidemann S, Fraune C, Büscheck F, Hube-Magg C, Möller-Koop C, Dahlem R, Fisch M, Rink M, Riechardt S, Burandt E, Bernreuther C, Minner S, Simon R, Sauter G, Wilczak W, Clauditz T. Eichenauer T, et al. Among authors: moller koop c. World J Surg Oncol. 2020 Jun 13;18(1):128. doi: 10.1186/s12957-020-01902-y. World J Surg Oncol. 2020. PMID: 32534597 Free PMC article.
Up-regulation of mismatch repair genes MSH6, PMS2 and MLH1 parallels development of genetic instability and is linked to tumor aggressiveness and early PSA recurrence in prostate cancer.
Wilczak W, Rashed S, Hube-Magg C, Kluth M, Simon R, Büscheck F, Clauditz TS, Grupp K, Minner S, Tsourlakis MC, Möller-Koop C, Graefen M, Adam M, Haese A, Wittmer C, Sauter G, Izbicki JR, Huland H, Schlomm T, Steurer S, Krech T, Lebok P. Wilczak W, et al. Carcinogenesis. 2017 Jan;38(1):19-27. doi: 10.1093/carcin/bgw116. Epub 2016 Nov 1. Carcinogenesis. 2017. PMID: 27803051
Deletion of 18q is a strong and independent prognostic feature in prostate cancer.
Kluth M, Graunke M, Möller-Koop C, Hube-Magg C, Minner S, Michl U, Graefen M, Huland H, Pompe R, Jacobsen F, Hinsch A, Wittmer C, Lebok P, Steurer S, Büscheck F, Clauditz T, Wilczak W, Sauter G, Schlomm T, Simon R. Kluth M, et al. Oncotarget. 2016 Dec 27;7(52):86339-86349. doi: 10.18632/oncotarget.13404. Oncotarget. 2016. PMID: 27861151 Free PMC article.
Deletion of 8p is an independent prognostic parameter in prostate cancer.
Kluth M, Amschler NN, Galal R, Möller-Koop C, Barrow P, Tsourlakis MC, Jacobsen F, Hinsch A, Wittmer C, Steurer S, Krech T, Büscheck F, Clauditz TS, Beyer B, Wilczak W, Graefen M, Huland H, Minner S, Schlomm T, Sauter G, Simon R. Kluth M, et al. Oncotarget. 2017 Jan 3;8(1):379-392. doi: 10.18632/oncotarget.13425. Oncotarget. 2017. PMID: 27880722 Free PMC article.
Integrating Tertiary Gleason 5 Patterns into Quantitative Gleason Grading in Prostate Biopsies and Prostatectomy Specimens.
Sauter G, Clauditz T, Steurer S, Wittmer C, Büscheck F, Krech T, Lutz F, Lennartz M, Harms L, Lawrenz L, Möller-Koop C, Simon R, Jacobsen F, Wilczak W, Minner S, Tsourlakis MC, Chirico V, Weidemann S, Haese A, Steuber T, Salomon G, Matiu M, Vettorazzi E, Michl U, Budäus L, Tilki D, Thederan I, Pehrke D, Beyer B, Fraune C, Göbel C, Heinrich M, Juhnke M, Möller K, Bawahab AAA, Uhlig R, Huland H, Heinzer H, Graefen M, Schlomm T. Sauter G, et al. Eur Urol. 2018 May;73(5):674-683. doi: 10.1016/j.eururo.2017.01.015. Epub 2017 Jan 20. Eur Urol. 2018. PMID: 28117112
44 results